Occuity raised £2m to develop devices that provided non-invasive diabetes detection and personal management by the end of 2025.

The Thames Valley-based technology start-up reached its £1.8m investment target in just over 24 hours on crowdfunding platform Seedrs.

Dr Dan Daly, CEO and co-founder of Occuity, said: ‘We’re delighted with the level of interest we have received during this finance round and are thrilled that we are now overfunding. To date we have now raised over £2m which will allow us to accelerate the development of our new optical screening and monitoring devices that aim to detect the early signs of chronic health conditions by scanning the human eye.’